Medicine and Dentistry
Patient
100%
Inpatient
32%
Myeloproliferative Neoplasm
30%
Therapeutic Procedure
29%
Thrombosis
26%
Phlebothrombosis
21%
Myelofibrosis
19%
Venous Thromboembolism
19%
Polycythemia vera
19%
Diagnosis
18%
Essential Thrombocythaemia
18%
Combination Therapy
16%
Platelet
15%
Pregnancy
13%
Multiple Myeloma
10%
Woman
9%
Thrombophilia
9%
Incidence
9%
Antithrombotic
9%
Acetylsalicylic Acid
9%
Prophylaxis
9%
Myeloproliferative Disorder
9%
Diseases
8%
Complication
8%
Budd-Chiari Syndrome
8%
Vitamin K Antagonist
8%
Age
8%
Acute Coronary Syndrome
8%
Hydroxyurea
7%
Prothrombin G20210A
7%
Follow up
7%
Gene
7%
Blood
7%
Analysis
6%
Neoplasm
6%
Recurrent Disease
6%
Second Cancer
6%
Donor
6%
Meta-Analysis
6%
Bleeding
5%
Drug
5%
Chemotherapeutic Agent
5%
PET-CT
5%
Anticoagulation
5%
Acute Leukemia
5%
Spliceosome
5%
Epigenomics
5%
Alkylating Antineoplastic Agent
5%
Ruxolitinib
5%
Artery Thrombosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
16%
Thrombosis
15%
Polycythemia vera
12%
Thrombocythemia
12%
Myelofibrosis
10%
Vein Thrombosis
8%
Liver Cirrhosis
8%
Myeloproliferative Neoplasm
7%
Incidence
7%
Portal Vein Thrombosis
6%
Heparin
6%
Acetylsalicylic Acid
5%
Lymphoma
5%
Fondaparinux
5%
Alkylating Agent
5%
Antivitamin K
5%
